Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Urinary incontinence
Medicine of older adults · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Retention, sepsis or acute neurological bladder
Painful retention, anuria with distension, urosepsis, macroscopic haematuria with clots, new saddle anaesthesia or leg weakness, or obstructed infected urinary tract requires urgent decompression and cause treatment.
Action: Use ABCDE and glucose, perform focused abdominal and neurological assessment, measure bladder volume, obtain urine and renal tests, drain when acute retention is confirmed using an appropriate catheter plan, and activate sepsis, urology or spinal pathways.
Overview
Classify urinary leakage without dismissing it as ageing, identify retention, infection, neurological and cancer danger, and provide conservative, pharmacological and referral care adapted to cognition, mobility, renal function and personal goals.
Ask the person what leakage means in daily life and what improvement would matter. Characterise onset, urgency, cough or exertional leak, frequency, nocturia, enuresis, continuous wetness, stream, hesitancy, straining, emptying and pad use. Quantify fluids, caffeine and alcohol. Ask dysuria, haematuria, pelvic symptoms, bowel loading, neurological symptoms, falls and sleep. Obtain collateral and care records when cognition limits detail.
Look for transient contributors without using a mnemonic as a substitute for assessment: delirium, symptomatic infection, atrophic symptoms, medicines, high urine output, restricted mobility and stool loading. Reconcile diuretics, sedatives, anticholinergics, opioids and drugs affecting glucose or oedema. Time diuretics thoughtfully but do not move or stop heart-failure therapy without monitoring congestion and renal function.
Aetiology
01
Urgency incontinence
Detrusor overactivity, bladder irritation, neurological disease and impaired central inhibition produce urgency followed by leakage before reaching a toilet.
02
Stress incontinence
Urethral support or sphincter weakness allows leakage when cough, exertion or movement raises abdominal pressure beyond outlet resistance.
03
Voiding dysfunction and overflow
Outlet obstruction, detrusor underactivity, anticholinergics, constipation and neuropathy leave a high residual that leaks intermittently between incomplete voids.
Involuntary detrusor contraction, reduced capacity or weak outlet closure allows urine loss before intended voiding can occur safely.
2
Emptying failure
Obstruction or weak detrusor contraction raises residual volume, causing frequency, recurrent infection, overflow and sometimes renal damage.
3
Sensory and cortical change
Neuropathy, dementia and stroke alter bladder sensation, inhibition and the ability to interpret or act on urgency.
4
Environment-function mismatch
Short warning time becomes leakage when gait speed, transfers, clothing or toilet access cannot meet the bladder's demand.
5
Medicine-mediated dysfunction
Diuretics increase volume, sedatives delay response, antimuscarinics impair emptying and alpha blockade or cholinergic effects alter outlet control.
Clinical features and red flags
Urgency incontinence
A compelling difficult-to-defer urge precedes leakage, often with frequency and nocturia.
Stress incontinence
Coughing, laughing, lifting or exertion produces small-volume leakage without preceding urgency.
Mixed incontinence
Both urgency and exertional leakage occur; treatment targets the symptom with greatest impact first.
Overflow patternRed flag
Weak stream, incomplete emptying, dribbling and a high residual indicate voiding failure.
Functional incontinence
Mobility, cognition, clothing or toilet access prevents timely voiding despite a potentially functional bladder.
Acute neurological bladderRed flag
Retention or incontinence with saddle or bilateral leg signs requires emergency spinal assessment.
Red flags requiring action
New urinary retention with saddle sensory loss, bilateral weakness or severe back pain requires emergency cauda equina assessment.
Fever, rigors, hypotension, delirium or flank pain with urinary symptoms requires sepsis and upper-tract obstruction assessment.
Visible haematuria, recurrent unexplained infection, pelvic mass or weight loss requires cancer-appropriate investigation.
Investigations
01Three-day bladder diaryFirst stepFirst line
Why
Classify storage, volume and timing patterns first line.
Interpretation and limitations
Record time and volume of intake and voids, urgency, leakage and pads; distinguish frequency from global or nocturnal polyuria.
02Urinalysis and selected culture
Why
Detect haematuria, glycosuria and symptomatic infection.
Interpretation and limitations
Interpret with symptoms and population; bacteriuria alone in an older person does not establish symptomatic UTI.
03Post-void residual ultrasound
Why
Identify incomplete emptying and overflow.
Interpretation and limitations
Use after a representative void and repeat or escalate a persistently large residual in clinical and renal context.
04Pelvic, prostate and neurological examination
Why
Identify prolapse, atrophy, outlet and neurological causes.
Interpretation and limitations
Tailor to symptoms, consent and sex; emergency spinal signs and masses take priority over routine continence treatment.
05Renal, glucose and targeted blood tests
Why
Assess polyuria, renal harm and medicine safety.
Differential diagnosis
01
Urinary tract infection
Acute dysuria, frequency and systemic features support infection, but chronic leakage or asymptomatic bacteriuria should not be conflated with UTI.
02
Polyuria
Diabetes, hypercalcaemia, diuretics and excess fluid cause high-volume frequency rather than primary loss of storage control.
03
Retention with overflow
Weak stream, hesitancy, incomplete emptying and palpable bladder distinguish overflow from uncomplicated overactive bladder symptoms alone.
04
Pelvic or urological disease
Prolapse, prostate obstruction, stone, tumour, atrophy and fistula require examination and targeted referral through the appropriate pathway.
05
Functional toileting failure
Leakage occurs because delirium, dementia, pain, mobility or environment prevents access despite no major lower-tract pathology.
Management
01First-line classificationIdentify subtype and reversible contributorsFirst stepFirst lineAn older adult reports new or persistent urinary leakage.+
1Assess urgency, stress, voiding, volume, bowel, medicine, cognition, mobility and red flags and examine relevant systems.
2Use bladder diary, urine testing and post-void residual when indicated to distinguish storage, polyuria, infection and emptying failure.
3Agree a conservative plan targeted to subtype and function, with containment and skin protection while treatment develops.
02Urgency and functional routeTrain the bladder and enable the toilet journeyUrgency, frequency or access delay drives leakage without dangerous retention.+
1Offer at least six weeks of bladder training with fluid, caffeine, bowel and disease optimisation.
Complications
01
Skin and pressure damage
Persistent moisture and irritant exposure produce dermatitis and amplify pressure-injury risk around sacral and perineal skin.
02
Falls and restriction
Urgent night-time toilet trips cause rushing, falls and fear, while catheter or pad dependence can reduce activity.
03
Infection and retention
High residuals and indwelling catheters increase symptomatic infection, stones and upper-tract harm when drainage or care is inadequate.
04
Sleep and psychological harm
Nocturia, embarrassment, odour and fear of leakage cause fatigue, isolation, depression and sexual difficulty over time.
05
Carer and placement burden
Frequent prompted toileting, laundry and night care may exceed support capacity and precipitate crisis placement without additional help.
Monitoring and follow-up
Repeat bladder diary or agreed leakage and pad measure after the conservative treatment interval.
Review residual volume and renal status when voiding symptoms, neurological disease or retention risk persists.
During bladder medication, monitor blood pressure, cognition, constipation, dry mouth, falls and ability to empty.
Inspect perineal and pressure-prone skin and review absorbent-product fit and barrier care.
Reassess catheter indication, blockage, leakage, infection and the feasibility of intermittent alternatives.
Review the person's embarrassment, sleep, social participation and carer burden as treatment outcomes.
Special situations
Frequency is not always overactivity
A diary may reveal high urine volume from diabetes, diuretics or excessive intake rather than small bladder capacity.
The route can be the treatment
Lighting, clothing, transfer help and a reachable commode may prevent leakage without adding pharmacological burden.
Bacteriuria is common
A positive culture without compatible symptoms should not automatically trigger antibiotics or explain chronic incontinence.
Antimuscarinic effects travel
A bladder prescription can worsen cognition, bowel emptying, vision and falls far beyond the urinary tract.
Containment deserves review
Pads and catheters protect dignity in selected situations but can obscure treatable retention, skin harm or mobility restriction.
Common pitfalls
01
Calling urinary leakage an inevitable part of ageing.
02
Treating bacteriuria without compatible urinary or systemic symptoms.
03
Prescribing an antimuscarinic before checking constipation, cognition and emptying risk.
04
Missing overflow because frequency is assumed to prove overactive bladder.
05
Moving a diuretic without considering heart failure control and practical toilet access.
06
Writing prompted toileting without a feasible timing and carer plan.
07
Using a long-term catheter for convenience without a documented indication and review.
08
Ignoring visible haematuria or new neurological signs during routine continence care.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Medicine of older adultsOriginal SBA
First-line urgency management
An 81-year-old has urgency incontinence, a low residual volume and no infection or neurological red flags. Which initial treatment is most appropriate?
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Examine abdomen for distension or mass, perineal skin, mobility, cognition and relevant neurology. In women, pelvic examination can identify atrophy, prolapse, pelvic-floor contraction and mass when indicated; in men assess genitalia and prostate according to symptoms and consent. New saddle change, bilateral weakness or anal-tone concern requires emergency spinal assessment.
Use a bladder diary for at least three days where feasible, including work and leisure variation. Record voided volumes, intake, urgency, leakage and pad changes. The pattern identifies nocturnal or 24-hour polyuria, small functional capacity and triggers. A diary is both a diagnostic and monitoring tool and should not be replaced by asking how many times someone goes.
Urine testing follows symptoms and population. NICE recommends dipstick testing in the initial assessment of women with urinary incontinence. Culture when infection is clinically suspected under the relevant pathway; bacteriuria without local or systemic symptoms is common in older and catheterised people and generally should not trigger antibiotics. Persistent visible or qualifying non-visible haematuria follows the cancer pathway.
Measure post-void residual with ultrasound where voiding dysfunction, neurological disease, recurrent UTI or overflow is suspected. A single volume depends on bladder fullness, timing and circumstances and has no universal stand-alone threshold. Large persistent residual, renal impairment or upper-tract concern requires urology assessment. Urodynamics is reserved for selected diagnostic uncertainty or before certain invasive treatments.
For urgency or mixed incontinence, offer bladder training for at least six weeks. Agree progressively increasing intervals, urge-suppression strategies and a diary. Moderate excess caffeine and fluid without causing dehydration; treat constipation; optimise diabetes, oedema timing and toilet access. In cognitive impairment use prompted voiding linked to usual pattern and carer feasibility rather than instructions the person cannot retain.
For stress or mixed incontinence in women, supervised pelvic-floor muscle training for at least three months is first-line, with at least eight contractions three times daily in the NICE programme after confirming a correct contraction. Adapt for pain, cognition and adherence. Surgery or specialist devices require confirmation of subtype, goals and operative risk rather than being excluded solely because of age.
When overactive bladder persists, discuss medicine benefit and burden. Review anticholinergic load, cognition, constipation, glaucoma, retention, renal and hepatic function and interactions. NICE advises against immediate-release oxybutynin in older women at higher risk of sudden physical or mental deterioration. Mirabegron avoids direct antimuscarinic effects but can raise blood pressure and still requires retention and interaction review.
Containment supports dignity while treatment proceeds: individually fitted absorbent products, barrier care, washable options and commodes or urinals placed safely. Long-term indwelling catheterisation is not routine management of uncomplicated incontinence; consider it for specific retention, wound, comfort or end-of-life indications after risks and alternatives. Review continued need and catheter care.
Coordinate continence nursing, pelvic health physiotherapy, urology or urogynaecology, geriatrics, pharmacy, OT and social care according to findings. Monitor leakage and the outcomes the person values, plus residual, BP, cognition, bowel function and falls after treatment. A care-home plan should state toileting times, transfers, equipment, pads, skin care and escalation.
Key points
Classify leakage as urgency, stress, mixed, overflow, continuous or functional by history, diary, examination and residual volume when indicated.
Use urine dipstick in women as NICE advises and culture when symptomatic infection or testing criteria apply; do not treat asymptomatic bacteriuria routinely.
Measure post-void residual by bladder scan when voiding dysfunction, recurrent infection, neurological disease or overflow is suspected.
A three-day bladder diary records time, volume, intake, urgency and leakage and separates small-volume urgency from true polyuria.
First-line urgency management is bladder training for at least six weeks, fluid and caffeine adjustment, constipation treatment and mobility-access optimisation.
First-line stress or mixed incontinence care includes supervised pelvic-floor muscle training for at least three months, targeted to confirmed contraction ability.
In frailty or cognitive impairment, prompted or timed toileting, clear routes, clothing adaptation and carer training may outperform another bladder drug.
Before an antimuscarinic, review cognition, constipation, glaucoma risk, emptying and total anticholinergic burden; avoid immediate-release oxybutynin in frail older women.
Painful palpable bladder, overflow leakage or acute kidney injury requires urgent residual-volume and obstruction assessment.
Continuous leakage after pelvic surgery or radiotherapy can indicate fistula and requires specialist review.
Sudden new incontinence with delirium, marked thirst, hyperglycaemia or medication change should trigger acute reversible-cause assessment.
Interpretation and limitations
Use renal function, HbA1c or glucose and calcium or other tests when the diary and examination support a metabolic or obstructive cause.
06Urodynamic testing
Why
Resolve selected uncertainty before invasive treatment.
Interpretation and limitations
Not routine for straightforward initial care; use specialist testing when subtype, voiding dysfunction or prior treatment makes the result actionable.
07Functional toilet assessment
Why
Find environmental and carer barriers to continence.
Interpretation and limitations
OT or continence staff assess transfers, route, clothing, aid, commode, cognition, prompting and night-time support.
2
Use prompted or timed toileting, clear routes, simple clothing and safe commode or urinal placement when cognition or mobility limits response.
3If burden persists, discuss pharmacological options with anticholinergic, BP, residual, renal and interaction assessment.
03Stress incontinence routeBuild outlet support before escalationEscalationLeakage occurs with exertion or mixed symptoms include a bothersome stress component.+
1Confirm a correct pelvic-floor contraction and offer supervised training for at least three months.
2Review adherence, weight, cough, constipation, atrophy and functional barriers and quantify change with diary or pad use.
3EscalationRefer for specialist conservative or surgical options when symptoms remain unacceptable and goals and risk support escalation.
04Retention and complication routeProtect bladder and kidneysHigh residual, recurrent infection, renal decline, haematuria or neurological signs are present.+
1Assess urgently for acute retention, sepsis, spinal disease or clot obstruction and drain or treat under the relevant pathway.
2Review outlet disease, constipation, medicines and neurological causes and obtain renal or upper-tract assessment when indicated.
3Use intermittent or indwelling catheter strategies only for a defined indication with training, infection prevention and review.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions+
Treatment of urgency, increased frequency and urgency incontinence from overactive bladder when an antimuscarinic is unsuitable, ineffective or not tolerated.
Mirabegron prolonged-release
The usual adult dose is 50 mg orally once daily, swallowed whole; use 25 mg once daily for specified severe renal or moderate hepatic impairment and follow the current product interaction table.
Check blood pressure before and during treatment; avoid severe uncontrolled hypertension, review urinary retention and CYP2D6 interactions, and do not use in end-stage renal or severe hepatic impairment.
Mirabegron is an option for overactive bladder when antimuscarinics are contraindicated, ineffective or not tolerated, with blood-pressure, interaction, renal and hepatic review.